The detection and implication of genome instability in cancer

Cancer and Metastasis Reviews

Volumn 32, Issue 3-4, 2013, Pages 341-352

  Pikor, Larissa ^a,b   Thu, Kelsie ^a,b   Vucic, Emily ^a,b   Lam, Wan ^a,b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cancer; CIN; Genomic instability; MSI; Nucleotide instability

Indexed keywords

DNA; NUCLEOTIDE; PROTEIN P53;

ADVANCED CANCER; ANEUPLOIDY; ARTICLE; CANCER RESEARCH; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CHROMOSOME NUMBER; DNA DAMAGE; GENE MUTATION; GENOME; GENOMIC INSTABILITY; HUMAN; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; PRECANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENETIC TESTING; GENOMIC INSTABILITY; GENOMICS; HUMANS; NEOPLASMS;

EID: 84890312233     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-013-9429-5     Document Type: Article

References (91)

1. Sieber, O. M., Heinimann, K., & Tomlinson, I. P. (2003). Genomic instability - the engine of tumorigenesis? Nature Reviews. Cancer, 3(9), 701-708.
2. Nowell, P. C. (1976). The clonal evolution of tumor cell populations. Science, 194(4260), 23-28.
3. Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997). Genetic instability in colorectal cancers. Nature, 386(6625), 623-627.
4. Gorgoulis, V. G., Vassiliou, L. V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 434(7035), 907-913.
5. Loeb, L. A. (2001). A mutator phenotype in cancer. Cancer Research, 61(8), 3230-3239.
6. Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature, 434(7035), 864-870.
7. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 444(7119), 633-637.
8. Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008). An oncogene-induced DNA damage model for cancer development. Science, 319(5868), 1352-1355.
9. Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J., & Medema, R. H. (2011). Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science, 333(6051), 1895-1898.
10. Hackett, J. A., & Greider, C. W. (2002). Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene, 21(4), 619-626.
11. Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., et al. (2011). Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell, 144(1), 27-40.
12. Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature, 396(6712), 643-649.
13. Boland, C. R., & Goel, A. (2010). Microsatellite instability in colorectal cancer. Gastroenterology, 138(6), 2073-2087. e2073.
14. Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., et al. (2008). Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26(35), 5705-5712.
15. Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szallasi, Z. (2006). A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genetics, 38(9), 1043-1048.
16. Dworaczek, H., & Xiao, W. (2007). Xeroderma pigmentosum: a glimpse into nucleotide excision repair, genetic instability, and cancer. Critical Reviews in Oncogenesis, 13(2), 159-177.
17. Al-Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N., Livingston, A. L., Williams, G. T., et al. (2002). Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nature Genetics, 30(2), 227-232.
18. Lee, H. C., Li, S. H., Lin, J. C., Wu, C. C., Yeh, D. C., & Wei, Y. H. (2004). Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutation Research, 547(1-2), 71-78.
19. Lee, H. C., Yin, P. H., Lin, J. C., Wu, C. C., Chen, C. Y., Wu, C. W., et al. (2005). Mitochondrial genome instability and mtDNA depletion in human cancers. Annals of the New York Academy of Sciences, 1042, 109-122.
20. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., et al. (1992). A second-generation linkage map of the human genome. Nature, 359(6398), 794-801.
21. Thibodeau, S. N., Bren, G., & Schaid, D. (1993). Microsatellite instability in cancer of the proximal colon. Science, 260(5109), 816-819.
22. Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993). Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 363(6429), 558-561.
23. Risinger, J. I., Berchuck, A., Kohler, M. F., Watson, P., Lynch, H. T., & Boyd, J. (1993). Genetic instability of microsatellites in endometrial carcinoma. Cancer Research, 53(21), 5100-5103.
24. Rhyu, M. G., Park, W. S., & Meltzer, S. J. (1994). Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene, 9(1), 29-32.
25. Halling, K. C., Harper, J., Moskaluk, C. A., Thibodeau, S. N., Petroni, G. R., Yustein, A. S., et al. (1999). Origin of microsatellite instability in gastric cancer. The American Journal of Pathology, 155(1), 205-211.
26. Kim, W. S., Park, C., Hong, S. K., Park, B. K., Kim, H. S., & Park, K. (2000). Microsatellite instability (MSI) in non-small cell lung cancer (NSCLC) is highly associated with transforming growth factor-beta type II receptor (TGF-beta RII) frameshift mutation. Anticancer Research, 20(3A), 1499-1502.
27. Fishel, R., Lescoe, M. K., Rao, M. R., Copeland, N. G., Jenkins, N. A., Garber, J., et al. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75(5), 1027-1038.
28. Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., et al. (1993). Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75(6), 1215-1225.
29. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., et al. (1994). Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 368(6468), 258-261.
30. Nicolaides, N. C., Papadopoulos, N., Liu, B., Wei, Y. F., Carter, K. C., Ruben, S. M., et al. (1994). Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature, 371(6492), 75-80.
31. Palombo, F., Gallinari, P., Iaccarino, I., Lettieri, T., Hughes, M., D'Arrigo, A., et al. (1995). GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science, 268(5219), 1912-1914.
32. Papadopoulos, N., Nicolaides, N. C., Wei, Y. F., Ruben, S. M., Carter, K. C., Rosen, C. A., et al. (1994). Mutation of a mutL homolog in hereditary colon cancer. Science, 263(5153), 1625-1629.
33. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J. P. (1999). CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America, 96(15), 8681-8686.
34. Issa, J. P. (2004). CpG island methylator phenotype in cancer. Nature Reviews. Cancer, 4(12), 988-993.
35. Goel, A., Nagasaka, T., Arnold, C. N., Inoue, T., Hamilton, C., Niedzwiecki, D., et al. (2007). The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology, 132(1), 127-138.
36. Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M., et al. (2009). CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut, 58(1), 90-96.
37. Vilar, E., & Gruber, S. B. (2010). Microsatellite instability in colorectal cancer - the stable evidence. Nature Reviews. Clinical Oncology, 7(3), 153-162.
38. Ward, R., Meagher, A., Tomlinson, I., O'Connor, T., Norrie, M., Wu, R., et al. (2001). Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut, 48(6), 821-829.
39. Gagos, S., & Irminger-Finger, I. (2005). Chromosome instability in neoplasia: chaotic roots to continuous growth. The International Journal of Biochemistry & Cell Biology, 37(5), 1014-1033.
40. Lee, A. J., Endesfelder, D., Rowan, A. J., Walther, A., Birkbak, N. J., Futreal, P. A., et al. (2011). Chromosomal instability confers intrinsic multidrug resistance. Cancer Research, 71(5), 1858-1870.
41. Walther, A., Houlston, R., & Tomlinson, I. (2008). Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut, 57(7), 941-950.
42. Solomon, D. A., Kim, T., Diaz-Martinez, L. A., Fair, J., Elkahloun, A. G., Harris, B. T., et al. (2011). Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science, 333(6045), 1039-1043.
43. O'Sullivan, R. J., & Karlseder, J. (2010). Telomeres: protecting chromosomes against genome instability. Nature Reviews Molecular Cell Biology, 11(3), 171-181.
44. Levitt, N. C., & Hickson, I. D. (2002). Caretaker tumour suppressor genes that defend genome integrity. Trends in Molecular Medicine, 8(4), 179-186.
45. Rotman, G., & Shiloh, Y. (1998). ATM: from gene to function. Human Molecular Genetics, 7(10), 1555-1563.
46. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K., Markowitz, S. D., et al. (1998). Mutations of mitotic checkpoint genes in human cancers. Nature, 392(6673), 300-303.
47. Hanks, S., Coleman, K., Reid, S., Plaja, A., Firth, H., Fitzpatrick, D., et al. (2004). Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nature Genetics, 36(11), 1159-1161.
48. Li, Y., & Benezra, R. (1996). Identification of a human mitotic checkpoint gene: hsMAD2. Science, 274(5285), 246-248.
49. Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010). Genomic instability - an evolving hallmark of cancer. Nature Reviews Molecular Cell Biology, 11(3), 220-228.
50. Maher, C. A., & Wilson, R. K. (2012). Chromothripsis and human disease: piecing together the shattering process. Cell, 148(1-2), 29-32.
51. Forment, J. V., Kaidi, A., & Jackson, S. P. (2012). Chromothripsis and cancer: causes and consequences of chromosome shattering. Nature Reviews. Cancer, 12(10), 663-670.
52. Abdel-Rahman, W. M., Katsura, K., Rens, W., Gorman, P. A., Sheer, D., Bicknell, D., et al. (2001). Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proceedings of the National Academy of Sciences of the United States of America, 98(5), 2538-2543.
53. Muresu, R., Sini, M. C., Cossu, A., Tore, S., Baldinu, P., Manca, A., et al. (2002). Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer. European Journal of Cancer, 38(13), 1802-1809.
54. Geigl, J. B., Obenauf, A. C., Schwarzbraun, T., & Speicher, M. R. (2008). Defining 'chromosomal instability'. Trends in Genetics: TIG, 24(2), 64-69.
55. Wan, T. S., & Ma, E. S. (2012). Molecular cytogenetics: an indispensable tool for cancer diagnosis. Chang Gung Medical Journal, 35(2), 96-110.
56. Beheshti, B., Park, P. C., Sweet, J. M., Trachtenberg, J., Jewett, M. A., & Squire, J. A. (2001). Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase FISH analysis. Neoplasia, 3(1), 62-69.
57. Bayani, J., & Squire, J. A. (2001). Advances in the detection of chromosomal aberrations using spectral karyotyping. Clinical Genetics, 59(2), 65-73.
58. Ye, C. J., Stevens, J. B., Liu, G., Bremer, S. W., Jaiswal, A. S., Ye, K. J., et al. (2009). Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer. Journal of Cellular Physiology, 219(2), 288-300.
59. Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012). Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science, 338(6114), 1622-1626.
60. Darzynkiewicz, Z., Halicka, H. D., & Zhao, H. (2010). Analysis of cellular DNA content by flow and laser scanning cytometry. Advances in Experimental Medicine and Biology, 676, 137-147.
61. D'Urso, V., Collodoro, A., Mattioli, E., Giordano, A., & Bagella, L. (2010). Cytometry and DNA ploidy: clinical uses and molecular perspective in gastric and lung cancer. Journal of Cellular Physiology, 222(3), 532-539.
62. Ishkanian, A. S., Malloff, C. A., Watson, S. K., DeLeeuw, R. J., Chi, B., Coe, B. P., et al. (2004). A tiling resolution DNA microarray with complete coverage of the human genome. Nature Genetics, 36(3), 299-303.
63. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., et al. (1998). High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genetics, 20(2), 207-211.
64. Heinrichs, S., & Look, A. T. (2007). Identification of structural aberrations in cancer by SNP array analysis. Genome Biology, 8(7), 219.
65. Zhao, X., Li, C., Paez, J. G., Chin, K., Janne, P. A., Chen, T. H., et al. (2004). An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Research, 64(9), 3060-3071.
66. Gondek, L. P., Tiu, R., Haddad, A. S., O'Keefe, C. L., Sekeres, M. A., Theil, K. S., et al. (2007). Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK, 21(9), 2058-2061.
67. Goel, A., Nagasaka, T., Hamelin, R., & Boland, C. R. (2010). An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers. PloS One, 5(2), e9393.
68. Janavicius, R., Matiukaite, D., Jakubauskas, A., & Griskevicius, L. (2010). Microsatellite instability detection by high-resolution melting analysis. Clinical Chemistry, 56(11), 1750-1757.
69. Meyerson, M., Gabriel, S., & Getz, G. (2010). Advances in understanding cancer genomes through second-generation sequencing. Nature Reviews Genetics, 11(10), 685-696.
70. Wheeler, D. A., Srinivasan, M., Egholm, M., Shen, Y., Chen, L., McGuire, A., et al. (2008). The complete genome of an individual by massively parallel DNA sequencing. Nature, 452(7189), 872-876.
71. Ng, P. C., & Kirkness, E. F. (2010). Whole genome sequencing. Methods in Molecular Biology, 628, 215-226.
72. Campbell, P. J., Stephens, P. J., Pleasance, E. D., O'Meara, S., Li, H., Santarius, T., et al. (2008). Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genetics, 40(6), 722-729.
73. Chiang, D. Y., Getz, G., Jaffe, D. B., O'Kelly, M. J., Zhao, X., Carter, S. L., et al. (2009). High-resolution mapping of copy-number alterations with massively parallel sequencing. Nature Methods, 6(1), 99-103.
74. Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., et al. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455(7216), 1069-1075.
75. Bell, D. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.
76. McLendon, R. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455(7216), 1061-1068.
77. Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., et al. (2012). The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 486(7403), 395-399.
78. Seo JS, Ju YS, Lee WC, Shin JY, Lee JK, Bleazard T, Lee J, Jung YJ, Kim JO, Yu SB et al. (2012). The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Research, 22, 2109-2119.
79. Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., et al. (2011). The genomic complexity of primary human prostate cancer. Nature, 470(7333), 214-220.
80. Jones, S., Zhang, X., Parsons, D. W., Lin, J. C., Leary, R. J., Angenendt, P., et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321(5897), 1801-1806.
81. Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjoblom, T., Leary, R. J., et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science, 318(5853), 1108-1113.
82. Mitelman, F., Johansson, B., & Mertens, F. (2004). Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nature Genetics, 36(4), 331-334.
83. Vollebergh, M. A., Jonkers, J., & Linn, S. C. (2012). Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers. Cellular and Molecular Life Sciences: CMLS, 69(2), 223-245.
84. Huang, Y. T., Lin, X., Liu, Y., Chirieac, L. R., McGovern, R., Wain, J., et al. (2011). Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America, 108(39), 16345-16350.
85. Massion, P. P., Zou, Y., Chen, H., Jiang, A., Coulson, P., Amos, C. I., et al. (2008). Smoking-related genomic signatures in non-small cell lung cancer. American Journal of Respiratory and Critical Care Medicine, 178(11), 1164-1172.
86. Thu, K. L., Vucic, E. A., Chari, R., Zhang, W., Lockwood, W. W., English, J. C., et al. (2012). Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability. PloS One, 7(3), e33003.
87. Bowtell, D. D. (2010). The genesis and evolution of high-grade serous ovarian cancer. Nature Reviews. Cancer, 10(11), 803-808.
88. Fang, M., Toher, J., Morgan, M., Davison, J., Tannenbaum, S., & Claffey, K. (2011). Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis. Cancer, 117(10), 2024-2034.
89. Lockwood, W. W., Wilson, I. M., Coe, B. P., Chari, R., Pikor, L. A., Thu, K. L., et al. (2012). Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development. PloS One, 7(5), e37775.
90. Wilkerson, M. D., Yin, X., Walter, V., Zhao, N., Cabanski, C. R., Hayward, M. C., et al. (2012). Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation. PloS One, 7(5), e36530.
91. Loeb, L. A. (2011). Human cancers express mutator phenotypes: origin, consequences and targeting. Nature Reviews. Cancer, 11(6), 450-457.